Integrated meta-analysis, network pharmacology, and molecular docking to investigate the efficacy and potential pharmacological mechanism of Kai-Xin-San on Alzheimer's disease

• Autores principales: Pengji Yi (Autor), Zheyu Zhang (Autor), Siqi Huang (Autor), Jiahua Huang (Autor), Weijun Peng (Autor), Jingjing Yang (Autor)
• Formato: Libro
• Publicado: Taylor & Francis Group, 2020-01-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Context Kai-Xin-San (KXS) has been used to treat Alzheimer's disease (AD) for thousands of years. However, no quantitative data regarding AD treatment using KXS are available. Moreover, its active compounds and mechanism of action for the treatment of AD remain largely unclear. Objectives To ev...